Ojemda Prices, Coupons, Copay Cards & Patient Assistance
Ojemda (tovorafenib) is a member of the multikinase inhibitors drug class and is commonly used for Low-Grade Glioma.
The cost for Ojemda 100 mg oral tablet is around $37,664 for a supply of 16 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Ojemda is available as a brand name drug only, a generic version is not yet available. View generic Ojemda availability for more details.
Ojemda prices
Oral Suspension
25 mg/mL
Ojemda oral suspension
from $9,423.56
for 12 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 12 milliliters | $785.30 | $9,423.56 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Oral Tablet
100 mg
Ojemda oral tablet
from $37,664.25
for 16 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 16 (4 x 4 each) | $2,354.02 | $37,664.25 |
| 20 (5 x 4 each) | $1,883.21 | $37,664.25 |
| 24 (6 x 4 each) | $1,569.34 | $37,664.25 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Ojemda Coupons, Copay Cards and Rebates
Ojemda offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
No manufacturer promotions could be found for this medication.
Patient Assistance & Copay Programs for Ojemda
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: EveryDay Support From Day One
Eligibility requirements:- Determined case by case
- Based on FPL
- Medically Necessary as determined by a Doctor
- Must be residing in the US or a US territory, and under the care of a US physician
- Co-payment assistance, and patient assistance programs are available for eligible patients.
- Ojemda (tovorafenib) Oral Suspension
- Ojemda (tovorafenib) Tablet
More information please phone: 855-329-1246 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Dabrafenib
Dabrafenib systemic is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Trametinib
Trametinib systemic is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer ...
More about Ojemda (tovorafenib)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- En español
